WASHINGTON D.C. –The Food and Drug Administration has warned the controversial host of Info Wars Alex Jones to stop claiming the products sponsored on his show prevent coronavirus.
According to KTXS, the FDA claims Jones promoted toothpaste, mouth wash, and other products that alleged to prevent the virus. Jones was also sent a cease-and-desist letter by New York's attorney general Letita James demanding he stop promoting phony products.
The FDA has not approved any treatments or vaccines against the coronavirus. The National Institutes of Health says no scientific evidence exists to suggest alternative remedies help.
According to the FDA, Inforwars.com has “48 hours to remove or correct the false material.”
The warning isn’t legally binding, but the agency can take individuals to court if the warning is ignored.
Subscribe to the LIVE! Daily
Required
Comments
Let me help you finish your reporting, Sonia. Alex Jones advocated the used of colloidal silver in oral care products due to its long known properties of being antibacterial, antifungal, and ANTIVIRAL. The fact that the FDA is sending him threats over something with scientific validity shows us all that they are 100% looking to make a profit off of selling toxic pharmaceuticals as a bandaid for this virus. They will tell you all sorts of lies to make that happen. This guy isn't selling snake oil. He's giving people the SAME AMOUNT OF OPTIONS as the FDA is giving us, which is either little or nothing. I guess what they about the government hating competition is true. By the way, Sonia, did you do any personal research into this topic? No? Hmmm not very investigative of you...
- Log in or register to post comments
PermalinkColloidal silver has been known to turn people blue. If nothing else, Alex Jones' listeners may turn into Smurfs, which would at least be something to laugh at.
- Log in or register to post comments
Permalink...but remember Julian Assange and WikiLeaks?
- Log in or register to post comments
PermalinkShould I be familiar?
- Log in or register to post comments
PermalinkPost a comment to this article here: